1. Home
  2. NSP vs DMRA Comparison

NSP vs DMRA Comparison

Compare NSP & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$48.35

Market Cap

1.8B

ML Signal

HOLD

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$28.82

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NSP
DMRA
Founded
1986
2011
Country
United States
United States
Employees
N/A
7
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
NSP
DMRA
Price
$48.35
$28.82
Analyst Decision
Hold
Buy
Analyst Count
3
2
Target Price
$47.67
$43.00
AVG Volume (30 Days)
591.0K
841.0K
Earning Date
04-30-2026
05-11-2026
Dividend Yield
6.45%
N/A
EPS Growth
N/A
N/A
EPS
0.88
N/A
Revenue
$6,812,000,000.00
N/A
Revenue This Year
$3.45
N/A
Revenue Next Year
$6.95
N/A
P/E Ratio
$54.52
N/A
Revenue Growth
3.51
N/A
52 Week Low
$18.57
$16.50
52 Week High
$61.65
$34.89

Technical Indicators

Market Signals
Indicator
NSP
DMRA
Relative Strength Index (RSI) 62.54 53.60
Support Level $32.75 $22.71
Resistance Level N/A N/A
Average True Range (ATR) 2.38 2.72
MACD -0.17 -0.19
Stochastic Oscillator 66.08 35.35

Price Performance

Historical Comparison
NSP
DMRA

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: